SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

Shanghai Pharmaceuticals Holding Co., Ltd

601607

CNE000000C82

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
17.81 ^CNY	+0.34%		+1.89%	+6.46%

Apr. 01	Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%	MT
Mar. 28	Shanghai Pharmaceuticals Holding Co., Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable Before 30 August 2024	CI

Shanghai Pharmaceuticals Holding Co., Ltd Announces Final Dividend for the Year Ended December 31, 2021, Payable on August 30, 2022

March 29, 2022 at 07:02 pm EDT

Shanghai Pharmaceuticals Holding Co. Ltd. announced final dividend of RMB 4.2 per 10 share for the year ended December 31, 2021 with payable date as August 30, 2022.

Latest news about Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharma's Profit Plunges 33% in 2023 Despite 12% Revenue Growth; Shanghai Shares Rise 4%	Apr. 01	MT
Shanghai Pharmaceuticals Holding Co., Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable Before 30 August 2024	Mar. 28	CI
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Shanghai Pharmaceuticals Gets Nod to Register Amiodarone Hydrochloride Injection	Mar. 22	MT
Shanghai Pharma Names Chairman; Vice Chairman Resigns	Mar. 20	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Executive Changes	Mar. 19	CI
Shanghai Pharma Unit's Citicoline Sodium Injection Passes Regulatory Evaluation	Mar. 08	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong	Feb. 20	CI
Shanghai Pharma Receives Approval For New Dosage of Leukemia Drug	Feb. 13	MT
Shanghai Pharma, Yunnan Baiyao Renew Sales, Procurement Deal	Dec. 22	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Joint Company Secretary	Dec. 21	CI
Shanghai Pharmaceuticals Holding Gets Fine for Anti-Monopoly Violations	Dec. 17	MT
China Aproves Phase 1 Clinical Trial of Shanghai Pharma Subsidiary's Capsule for Tumors	Dec. 08	MT
Shanghai Pharma's Ex-Vice President Becomes Sixth Senior Exec to Face Probe	Nov. 23	MT
Shanghai Pharmaceuticals Chairman Steps Down	Nov. 20	MT
SIIC Environment Chairman Resigns	Nov. 19	MT
Shanghai Pharmaceuticals Holding Co., Ltd Announces Resignation of Zhou Jun as the Chairman of the Company, A Non-Executive Director	Nov. 19	CI
Shanghai Pharmaceuticals' Profit Up 6% in Q3	23-10-27	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Pharma’s Arthrits Drug Passes Generic Drug Consistency Test	23-10-05	MT
Shanghai Pharma’s Antibiotic Passes Generic Drug Consistency Evaluation in China	23-09-08	MT
China's CMOC to boost Congo copper output after ending row with Gecamines	23-09-07	RE
Shanghai Pharma’s Former Execs Face Probe	23-09-04	MT
Shanghai Pharmaceuticals’ H1 Profit Slides 29% Despite 19% Revenue Growth; Shanghai Shares Slump 8%	23-08-30	MT
Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI

Chart Shanghai Pharmaceuticals Holding Co., Ltd

Duration

Period

Chart Shanghai Pharmaceuticals Holding Co., Ltd

More charts

Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai Pharmaceuticals Holding Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.81 CNY

Average target price

20.78 CNY

Spread / Average Target

+16.68%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.46%	8.14B
MCKESSON CORPORATION	+16.62%	70.36B
CARDINAL HEALTH, INC.	+2.99%	25.18B
SINOPHARM GROUP CO. LTD.	+4.89%	8.61B
HUADONG MEDICINE CO., LTD	-21.01%	7.83B
H. LUNDBECK A/S	-0.61%	4.56B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-0.14%	4.06B
GALENICA AG	-3.30%	3.87B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.70%	3.61B

Pharmaceuticals Wholesale